Loading company…
Riskpilot
← Back to search
Sign in
Get full access
Aros Bio AB
AB
Active
Org 5591997126
Arosgatan 14
Computer programming activities · NACE 6210
Est. 2019
0 employees
Watchlist
Share
Download PDF
Full Risika report
Overview
Financials
People & ownership
Related companies
Revenue 2024
SEK 115K
+5% vs 2023
EBITDA margin
88.4%
+3% vs 2023
Equity ratio
77.3%
Financial strength
Net profit 2024
SEK 83K
+5% vs 2023
EBITDA — year on year
SEK millions
0M
0M
1M
1M
1M
0M
2019
0M
0%
2020
0M
0%
2021
0M
0%
2022
0M
0%
2023
0M
0%
2024
Key figures
Annual report 2024
Revenue
SEK 115K
+5%
EBITDA
SEK 102K
+3%
Net profit
SEK 83K
+5%
Total assets
SEK 304K
+39%
Equity
SEK 235K
+22%
Employees
0
—
Company information
Legal name
Aros Bio AB
Org number
5591997126
Legal form
Aktiebolag
NACE code
6210 · Computer programming activities
Founded
22 mars 2019
Share capital
SEK 50 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Försäljning av programvara och konsulttjänster inom livsvetenskaperna.
Contact
Address
Arosgatan 14
Email
ola.spjuth@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Computer programming activities
Companies in Uppsala
All Sweden companies
Revenue
SEK millions
0M
0M
1M
1M
1M
0M
2019
0M
2020
0M
2021
0M
2022
0M
2023
0M
2024
EBITDA
SEK millions
0M
0M
1M
1M
1M
0M
2019
0M
2020
0M
2021
0M
2022
0M
2023
0M
2024
Income statement
SEK thousands
Item
2019
2020
2021
2022
2023
2024
Revenue
—
160
127
100
110
115
Staff expenses
—
—
—
—
—
—
EBITDA
0
356
107
82
98
102
Depreciation & amort.
—
−0
−0
—
—
—
EBIT
0
356
107
82
98
102
Net financials
—
—
—
−0
1
2
Profit before tax
0
357
108
82
99
104
Tax
—
−74
−24
−17
−20
−21
Net profit
—
283
84
65
79
83
Balance sheet
SEK thousands
Item
2019
2020
2021
2022
2023
2024
Total assets
—
426
271
205
218
304
Equity
—
318
218
183
192
235
Long-term debt
—
0
0
—
—
—
Short-term debt
—
108
53
22
27
69
Total debt
—
108
53
22
27
69
Financial ratios
5-year trend
EBITDA margin
88.4%
This company
15.8%
Market median
+459% vs market
2019
2024
Equity ratio
77.3%
This company
38.2%
Market median
+102% vs market
2019
2024
Return on equity
35.3%
This company
18.4%
Market median
+92% vs market
2019
2024
Net profit margin
72.0%
This company
8.1%
Market median
+789% vs market
2019
2024
Asset turnover
0.38×
This company
1.12×
Market median
-66% vs market
2019
2024
Debt / equity
0.29×
This company
0.62×
Market median
+53% vs market
2019
2024
Annual reports & filings
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
View
PDF
Annual report 2019
Filed via Bolagsverket / SCB · Period 2019-03-01 – 2019-12-31
View
PDF
Management
Actively employed in the business
No data on file.
Board of directors
Non-executive oversight
Name
Role
Member since
Age
Other directorships
OS
Ola Spjuth
Board of Directors
2022
—
—
NS
Nora Sofia Spjuth
Deputy Board Member
2022
—
—
Shareholders
As of last annual report
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
No registered parent or subsidiaries
Board network connections
Board members of Aros Bio AB also hold positions in
0
other companies.
Person
Role here
Other companies
Ola Spjuth
Board of Directors
0 companies
Nora Sofia Spjuth
Deputy Board Member
0 companies